Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The trans-3-hexenoyl group on the N-terminal tyrosine acts as a protective cap against dipeptidyl peptidase-IV (DPP-IV), the enzyme that cleaves native GHRH between residues 2 and 3 and generates the short plasma half-life that limits unmodified GHRH activity
Price per mg honest breakdown Every FOXO4-DRI kit ships as 10 vials
The Elevated Dose is 4.8 mg (15 units), containing 3 mg GHK-Cu and 600 mcg each of BPC-157, TB-4, and KPV
Science 308 , 14661469 (2005)
No human data supports the injectable routes that are actually being used
At the post-transcriptional level, it has been demonstrated that the KEAP1-NRF2 system can be positively controlled by a microRNA (miRNA) able to target KEAP1 gene [178]
